Promising results in wound care with a new rapid capillary action dressing: a case series study

Alexandra Helena Jacoba Janssen; Janet Rijploeg; Johannes Wegdam; Tammo S De Vries; Hester Vermeulen; Anne Eskes

Promising results in wound care with a new rapid capillary action dressing: a case series study

Alexandra Helena Jacoba Janssen, Janet Rijploeg, Johannes Wegdam, Tammo S De Vries, Hester Vermeulen, Anne Eskes

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

This case series aimed to describe treatment effects and experiences of patients who switched from negative pressure wound therapy (NPWT) to a rapid capillary action dressing (RCAD; VACUTEX™). Ten consecutive patients who prematurely terminated NPWT were recruited. Mean time to complete wound closure was 87.3 days (SD 38.3). The main reasons for terminating NPWT were maceration of the skin caused by the film and patient discomfort. All patients preferred the RCAD, mainly because of better mobility and no noise, compared to the NPWT device. A RCAD appears to be a promising treatment modality.

Original language	English
Article number	12
Pages (from-to)	20
Number of pages	25
Journal	Wounds international
Volume	12
Issue number	3
Publication status	Published - 2 Sept 2021

Keywords

surgery
wounds and injuries

Cite this

@article{e1fcac8f6e5c4ab0b7a38a4ec8e9ab1d,

title = "Promising results in wound care with a new rapid capillary action dressing: a case series study",

abstract = "This case series aimed to describe treatment effects and experiences of patients who switched from negative pressure wound therapy (NPWT) to a rapid capillary action dressing (RCAD; VACUTEX{\texttrademark}). Ten consecutive patients who prematurely terminated NPWT were recruited. Mean time to complete wound closure was 87.3 days (SD 38.3). The main reasons for terminating NPWT were maceration of the skin caused by the film and patient discomfort. All patients preferred the RCAD, mainly because of better mobility and no noise, compared to the NPWT device. A RCAD appears to be a promising treatment modality.",

keywords = "surgery, wounds and injuries",

author = "Janssen, {Alexandra Helena Jacoba} and Janet Rijploeg and Johannes Wegdam and {De Vries}, {Tammo S} and Hester Vermeulen and Anne Eskes",

year = "2021",

month = sep,

day = "2",

language = "English",

volume = "12",

pages = "20",

journal = "Wounds international",

number = "3",

}

TY - JOUR

T1 - Promising results in wound care with a new rapid capillary action dressing: a case series study

AU - Janssen, Alexandra Helena Jacoba

AU - Rijploeg, Janet

AU - Wegdam, Johannes

AU - De Vries, Tammo S

AU - Vermeulen, Hester

AU - Eskes, Anne

PY - 2021/9/2

Y1 - 2021/9/2

N2 - This case series aimed to describe treatment effects and experiences of patients who switched from negative pressure wound therapy (NPWT) to a rapid capillary action dressing (RCAD; VACUTEX™). Ten consecutive patients who prematurely terminated NPWT were recruited. Mean time to complete wound closure was 87.3 days (SD 38.3). The main reasons for terminating NPWT were maceration of the skin caused by the film and patient discomfort. All patients preferred the RCAD, mainly because of better mobility and no noise, compared to the NPWT device. A RCAD appears to be a promising treatment modality.

AB - This case series aimed to describe treatment effects and experiences of patients who switched from negative pressure wound therapy (NPWT) to a rapid capillary action dressing (RCAD; VACUTEX™). Ten consecutive patients who prematurely terminated NPWT were recruited. Mean time to complete wound closure was 87.3 days (SD 38.3). The main reasons for terminating NPWT were maceration of the skin caused by the film and patient discomfort. All patients preferred the RCAD, mainly because of better mobility and no noise, compared to the NPWT device. A RCAD appears to be a promising treatment modality.

KW - surgery

KW - wounds and injuries

M3 - Article

VL - 12

SP - 20

JO - Wounds international

JF - Wounds international

IS - 3

M1 - 12

ER -